← Open Payments lookup

LAUREN ESCHMANN: Open Payments

NPI 1316475734 · AMERICUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$734 in 47 payments from 13 companies in 2025. Trend: 2023 $461 · 2024 $652 · 2025 $734

Food & beverage: $734
CompanyPaymentsAmount
GlaxoSmithKline, LLC.12$210
Novo Nordisk Inc16$184
AstraZeneca Pharmaceuticals LP4$71
ABBVIE INC.3$64
Lilly USA, LLC2$43
Amgen Inc.2$28
Ardelyx, Inc.1$27
Corcept Therapeutics1$21
Phathom Pharmaceuticals, Inc.2$20
Vanda Pharmaceuticals Inc.1$20

Products named: TRELEGY ELLIPTA, Ozempic, Rybelsus, AIRSUPRA, VRAYLAR, OTEZLA, IBSRELA, QULIPTA.

Industry payments across GA — which companies pay providers there.